Apellis Pharmaceuticals recently announced post hoc analysis data of the GALE extension study. This new data is the result of ...

A health care chatbot can be a patient's first point of contact for some sensitive conversations from mental health to ...

The EMERALD study carries significant implications across multiple stakeholders in ER+/HER2- metastatic breast cancer. For ...

Missing data in clinical trials remains an ongoing concern. With the expansion of data privacy efforts and the consequent inability to contact trial participants for follow-up, the magnitude and ...

Clinical trials are more connected and more closely examined than ever. Inspection readiness isn’t a last-minute document ...

Smart health refers to the integration of cutting-edge technologies into healthcare systems to improve patient care and apply ...